CardiologyTier 2Topic

The incidence of, and the risk factors for, cardiovascular disease in individuals and patient groups - patients with comorbidities

Overview

Cardiovascular disease risk and presentation are substantially modified by coexisting comorbidity - both in raising baseline risk and in altering how disease presents and is managed
Most cardiovascular risk calculators (e.g. Framingham-derived tools) systematically underestimate risk in several comorbid groups, requiring adjustment or a different approach

Diabetes - regarded as a coronary risk-equivalent in many frameworks; silent ischaemia is more common (autonomic neuropathy blunts anginal symptoms)
CKD - cardiovascular risk rises steeply with declining eGFR, independent of traditional risk factors; CKD patients are more likely to die of cardiovascular disease than to reach dialysis
Rheumatoid arthritis/inflammatory conditions - independent inflammatory contribution to atherosclerosis, comparable in magnitude to diabetes, often under-recognised and under-treated
HIV - accelerated atherosclerosis from chronic inflammation and some antiretroviral regimens

Standard risk calculators should be interpreted with an upward adjustment (or a comorbidity-specific tool used) in these groups, since unadjusted scores underestimate true risk

More aggressive risk factor modification (lower LDL targets, lower BP targets in several guidelines) is recommended for these higher-risk comorbid groups, alongside management of the underlying condition

Diabetes mellitus, chronic kidney disease, rheumatoid arthritis and other inflammatory disease, HIV

The presence of a qualifying comorbidity should itself trigger more intensive primary prevention, rather than waiting for a first cardiovascular event to escalate treatment

5 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.